This research study tests whether GLYX-13 — an experimental drug that acts on a brain receptor called NMDA — can decrease symptoms of OCD within hours. This is not a treatment study. Results from this study will allow doctors and researchers to better understand if you and others with OCD may respond to a class of medications that target the NMDA brain receptor.
You will be compensated for your time and travel.
6 CE or CME
Ticketed event (includes lunch):
ADAA mourns the loss of Robin Williams and too many others whose lives have ended due to suicide. His tragic death illustrates the great need for increased public awareness of the grave risk that suicide poses.
Every Tuesday and Thursday (3:00-3:30 pm ET) in October experts at the New York State Psychiatric Institute and Columbia University Department of Psychiatry will discuss diagnosis, new treatments, and resources for adults and children with OCD. More information and schedule.
Kids around the country share their stories of struggling with and managing their anxiety disorders in this special Nick News With Linda Ellerbee. Watch it here.
Dr. Jenny Yip addresses the challenges in diagnosing anxiety disorders in children, identifying the underlying cause of anxiety, and providing appropriate and effective treatment. Listen here.
Jenny C. Yip, PsyD, ABPP
Executive Director, Renewed Freedom Center for Rapid Anxiety Relief
Clinical Assistant Professor of Psychiatry, USC - Keck School of Medicine
Child & Adolescent Psychiatry Residency Program
Dr. Yip addresses the challenges in diagnosing anxiety disorders in children, identifying the underlying cause of anxiety, and providing appropriate and effective treatment.